Brief: Theravance Biopharma Q2 Operating Income USD -15.705 Million
05/08/2024 21:05
Aug 05 (Reuters) - Theravance Biopharma Q2 adjusted net income USD -6.25 million vs. IBES estimate USD -9.99 million. * Q2 net income USD -16.529 million
Recent news on Theravance Biopharma
See all newsTheravance Biopharma, Inc. reports results for the quarter ended June 30 - Earnings Summary
Ireland's Theravance Biopharma Q2 revenue rises 11% but misses estimates
Brief: Theravance Biopharma Q2 Operating Income USD -8.277 Million
Press Digest: Canada - June 30
Deals of the day-Mergers and acquisitions